Astaxanthin has been studied in 377 papers since 2000: 68 trials and 1 observational study in people, 86 in animals, 58 in cells, 145 reviews; 29 in the past year. Its furthest trials in people are at phase 3. The newest story, Nov 1, 2026: “Yoga plus a supplement linked to fewer depression symptoms”.
Worm studies and one study in male UM-HET3 mice report lifespan extension with astaxanthin; independent labs report reduced oxidative stress and inflammation in mice. Human trials report reductions or no clear effects on oxidative stress and inflammation. Some papers have company-affiliated authors or declare company ties.
274 findings in 93 papers from 2000 to 2026, 5 of them since May 2026
Independent labs found the same change in cells, worms or flies, mice and people. 57 independent labs in 21 countries; 7 trials, 1 about aging, 4 with no results posted.
“HYASG demonstrated the greatest improvements, with HAM-D scores decreasing by 45.1%, compared with 28.5% in HYG and 10.9% in ASG.”
Cells, worms or flies, mice and humans: replicated by independent labs.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
About aging: the drug’s trials about aging. The total counts its trials for every use.
No results posted: trials that ended over a year ago with no results on ClinicalTrials.gov and no paper reporting them.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
57 independent labs in 21 countries
15 findings against
7 trials, 1 about aging, 4 with no results posted
Funders: National Natural Science Foundation of China and others
Studies of astaxanthin measured 172 outcomes; the most studied are oxidative stress and ROS signaling (26 studies), inflammation (15) and lifespan (11).
Oxidative stress and ROS signaling
↓downin reviews10↓downin humans5↔no changein humans4↓downin human cells2+4
26 studies
Astaxanthin showed no clear effect on oxidative stress and ROS signaling in humans (fasting).
“Overall GLM analysis revealed no significant treatment effect (p<0.427, np2 = 0.100, medium effect) for AOPP, AGEs, and adiponectin.”
Journal of the International Society of Sports Nutrition·
Astaxanthin decreases oxidative stress and ROS signaling in humans.
“Between-group comparisons showed a statistically significant difference in the alterations of serum SOD levels between the AST and placebo groups (P = 0.027).”
Astaxanthin decreases oxidative stress and ROS signaling in humans (infertile PCOS patients).
“Overall, ASX appears to be an effective and safe supplement that alleviates insulin metabolism, lipid profile parameters, and OS in infertile PCOS patients.”
Human trialinfertile PCOS patients2 × 6 mg/day8 weeks
Astaxanthin decreases oxidative stress and ROS signaling in humans (infertile women with endometriosis stage III/IV undergoing ART) (14.619 ± 2.505 vs. 15.939 ± 1.512, P = 0.031).
“serum MDA (14.619 ± 2.505 vs. 15.939 ± 1.512; P = 0.031) decreased significantly following antioxidant treatment”
Human trialinfertile women with endometriosis stage III/IV undergoing ARTserum6 mg per day12 weeksfemalesn = 50
Astaxanthin decreases oxidative stress and ROS signaling.
“AST effectively mitigates oxidative stress and supports cellular health and longevity by neutralizing free radicals and upregulating endogenous antioxidant systems.”
Astaxanthin decreases oxidative stress and ROS signaling in experimental and preclinical models of neurodegenerative diseases.
“We highlight its role in mitigating oxidative stress, regulating mitochondrial function, modulating neuroinflammatory signaling, and promoting neurogenesis and synaptic remodeling.”
Reviewin experimental and preclinical models of neurodegenerative diseases
↓downin reviews6↓downin humans5↓downin mice2↓downin human cells1+1
15 studies
Astaxanthin decreases inflammation in humans (compared with C group) (d: 1.95, p < 0.001).
“Bonferroni’s post-hoc correction test for IL-36α revealed significantly lower levels in CT + P (d: 1.95, p < 0.001), CT (d: 2.42, p < 0.001), S (d: 1.95, p < 0.001), and CT + S (d: 3.29, p < 0.001) compared with C group.”
“Additionally, in the AST group, FF levels of IL-6 (P = 0 < 001), IL-8 (P = 0.036), and VEGF (P = 0.006) were significantly lower than in the placebo group.”
Astaxanthin decreases inflammation in humans (infertile women with endometriosis stage III/IV undergoing ART) (P = 0.000).
“significantly lower serum levels of IL-1β (4.515 ± 0.907 vs. 6.8760 ± 0.8478; P = 0.000), IL-6 (5.516 ± 0.646 vs. 5.0543 ± 0.709; P = 0.024) and TNF-α (2.520 ± 0.525 vs. 2.968 ± 0.548; P = 0.038) were observed after AST treatment”
Human trialinfertile women with endometriosis stage III/IV undergoing ARTserum6 mg per day12 weeksfemalesn = 50
“astaxanthin has exceptional antioxidant property, surpassing that of other carotenoids and conventional antioxidants, while also exerting robust anti-inflammatory effects.”
Astaxanthin extends lifespan in yeast cells (chronological lifespan in DNA repair-deficient mutant cells).
“Finally, we show that astaxanthin decreases the accumulation of mutation rate and enhances the longevity of DNA repair-deficient mutants' cells during a chronological lifespan.”
Cellschronological lifespan in DNA repair-deficient mutant cells
Astaxanthin inhibits apoptosis in yeast cells under oxidative stress compared to H2O2-treated cells.
“Astaxanthin pre-treated cells show a decrease in the levels of intracellular ROS, catalase activity, apoptosis, and an increase in mitochondrial membrane potential”
Cellsunder oxidative stress compared to H2O2-treated cells
Astaxanthin improves cognitive function in neurodegenerative aging.
“AST can modulate multiple molecular and cellular pathways involved in neuronal survival, synaptic plasticity, learning, and memory, particularly in the context of neurodegenerative aging.”
Astaxanthin improves cognitive function in humans within given contexts.
“Key findings include the positive impacts of astaxanthin in relation to improving cognitive function, facilitating neuroprotection, and slowing neurodegeneration within given contexts.”
Astaxanthin increases mitochondrial membrane potential in yeast cells under oxidative stress compared to H2O2-treated cells.
“Astaxanthin pre-treated cells show a decrease in the levels of intracellular ROS, catalase activity, apoptosis, and an increase in mitochondrial membrane potential”
Cellsunder oxidative stress compared to H2O2-treated cells
Astaxanthin decreases HbA1c in humans (5.64 ± 0.33 vs. 5.57 ± 0.39%).
“the levels of HbA1c (5.64 ± 0.33 vs. 5.57 ± 0.39%, p < 0.05), apo E (4.43 ± 1.29 vs. 4.13 ± 1.24 mg/dL, p < 0.05) and malondialdehyde-modified low-density lipoprotein (87.3 ± 28.6 vs. 76.3 ± 24.6 U/L, p < 0.05) were also reduced”
International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition·
International journal of environmental research and public health·
Astaxanthin improves muscle strength (particularly among older adults).
“AX enhances lipid utilization, promotes mitochondrial biogenesis through AMPK activation, and improves endurance and muscle strength, particularly among older adults.”
mitochondrial respiratory chain complex III biogenesis
↕mixedin worms1
1 study
Astaxanthin is associated with mitochondrial respiratory chain complex III biogenesis in worms (also indicated in mitochondria isolated from worms, rodents, human and plants).
“Astaxanthin affects the biogenesis of holo-complex III (and likely supercomplex I+III, as well)”
Model organismsalso indicated in mitochondria isolated from worms, rodents, human and plants
Independent labs report longer worm lifespan and reduced human inflammation with astaxanthin; a mouse study reports longer male lifespan, while other human trials report no change in inflammation or oxidative stress. One registered trial concerns aging; five trials across uses ended over a year ago without posted results or citing papers. Some papers declare company ties; Algatechnologies sponsors a trial.
One yeast-cell study shows that astaxanthin extends lifespan in short-lived mutant strains and, under oxidative stress, increases viability and mitochondrial membrane potential while reducing intracellular ROS and apoptosis.
Depression scores fell 45.1% with yoga plus astaxanthin, versus 28.5% with yoga and 10.9% with the supplement alone, in postmenopausal women.Depression scores fell 45.1% with yoga plus astaxanthin, versus 28.5% with yoga and 10.9% with the supplement alone, in postmenopausal women.